Articles

Women with breast cancer who have elevated levels of C-peptide (a marker of insulin secretion) have significantly higher mortality rates than their peers with lower levels, results of the Health, Eating, Activity, and Lifestyle (HEAL) study indicate.

 

Oral rivaroxaban’s efficacy at reducing the risk of recurrent venous thromboembolism (VTE) was confirmed in two trials presented at the annual meeting of the American Society of Hematology. The agent was studied for treatment of deep-vein thrombosis (DVT) as well as for continued therapy after initial anticoagulation treatment for DVT or pulmonary embolism.

 

For patients with a past history or family history of colorectal cancer, annual fecal immunochemical tests (FITs) detect neoplasias sooner than scheduled 10-year colonoscopies, according to a new study published in the December issue of Gastroenterology. For patients with FIT-positive results, diagnosis was made sooner by 25 months for cancer and by 24 months for advanced adenomas.

 

 

An adjuvant regimen of docetaxel, doxorubicin, and cyclophosphamide (TAC) is effective for women with high-risk, node-negative as well as node-positive breast cancer, according to a study by the Spanish Breast Cancer Research Group.

 

The taxane-based regimen has proved superior to fluorouracil, doxorubicin, and cyclophosphamide (FAC) in women with node-positive breast cancer, but its value in node-negative disease had not been determined.

 

Exercise programs should be initiated more widely among established androgen-deprivation therapy (ADT) users, argue the results of a new study by researchers at the University of Toronto. In addition, their study highlights the importance of further investigation into whether initiating exercise at the same time as that of ADT can reverse or prevent the negative physical outcomes often associated with ADT.

 

Adjuvant trastuzumab treatment may be beneficial for women with small human epidermal growth factor receptor 2 (HER2)-positive breast tumors, according to a review by British researchers.